Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Neos Therapeutics, Inc. | a2234488zex-32_1.htm |
| EX-31.2 - EX-31.2 - Neos Therapeutics, Inc. | a2234488zex-31_2.htm |
| EX-31.1 - EX-31.1 - Neos Therapeutics, Inc. | a2234488zex-31_1.htm |
| EX-21.1 - EX-21.1 - Neos Therapeutics, Inc. | a2234488zex-21_1.htm |
| EX-10.21 - EX-10.21 - Neos Therapeutics, Inc. | a2234488zex-10_21.htm |
| 10-K - 10-K - Neos Therapeutics, Inc. | a2234488z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-212809 and 333-219108) and Form S-8 (No. 333-2166698, No. 333-210267 and No. 333-205937) of Neos Therapeutics, Inc. of our report dated March 16, 2018, relating to the consolidated financial statements and the financial statement schedule of Neos Therapeutics and subsidiaries appearing in the Annual Report on Form 10-K of Neos Therapeutics, Inc. for the year ended December 31, 2017.
/s/
RSM US LLP
New York, New York
March 16, 2018
Consent of Independent Registered Public Accounting Firm